Live Roundups Editor's Desk Insights Executive Ops Weather About 🔍
Home › Business & Finance › Hua Medicine CEO Li Chen on Earnings
Business & Finance

Hua Medicine CEO Li Chen on Earnings

Bloomberg Markets Friday 21 August 2026, 07:32 UTC 1 min read
Key Points

Li Chen, Executive Director & CEO at Hua Medicine, discusses the Chinese biotech firm's growth plans exclusively on "Bloomberg: The China Show" following the company's first half results.

Li Chen, Executive Director & CEO at Hua Medicine, discusses the Chinese biotech firm's growth plans exclusively on "Bloomberg: The China Show" following the company's first half results. (Source: Bloomberg)
Hua Medicine (ORG) Li Chen (PERSON) Chinese (ORG) Bloomberg (PERSON)
Originally published by Bloomberg Markets Read original →

Related Stories

Japan weighs 3.8% assumed rate for next year's budget request, sources say

Japan weighs 3.8% assumed rate for next year's budget request, sources say TOKYO, Aug 21 : Japan's finance ministry is considering setting the assumed interest rate for calculating debt servicing costs at a 29-year high of 3.8 per cent in its budget request for next fiscal year, two government sources said on Friday. This would mark an increase from 3.0 per cent in the fiscal 2026 budget, and highlight the strain rising long-term interest rates are inflicting on Japan's stretched finances....

Channel News Asia 13m ago

Bitcoin on track for 20% weekly gain as investor optimism floods back

Bitcoin was on track for a weekly gain of around 20% early on Friday, following a spate of positive developments for the world's largest cryptocurrency. Bitcoin was last seen at $75,343.01, up from $62,836.88 at the start of the week. Crypto stocks followed suit on Thursday, with Coinbase and Circle closing up 7.5% and 6.45% each, while Strategy rose 7.8%.

CNBC 16m ago

Dollar Depreciation Is Sustainable: 3-Minutes MLIV

Guy Johnson, Tom Mackenzie, Skylar Montgomery Koning and Mark Cudmore break down today's key themes for analysts and investors on "Bloomberg: The Opening Trade."

Bloomberg Markets 16m ago

Memory Stocks Struggle for Momentum With ‘Smart Money’ Moving On

After ripping through the first half of the year, memory stocks are struggling to regain momentum as growing concerns about the state of the artificial intelligence trade overshadow their strong fundamental backdrop.

Bloomberg Markets 22m ago